Sinco Pharmaceuticals chair Huang Zhijian replaces late founder Huang Xiangbin as guarantor

• Sinco Pharmaceuticals said controlling shareholder and founder Huang Xiangbin, former executive director and board chairman, died on July 24, 2026.
• Executive director Huang Zhijian, the current board chairman, will replace Huang Xiangbin as guarantor for the group’s bank obligations.
• The prior guarantee agreement with Huang Xiangbin was terminated with immediate effect following his death.
• The board expects no material impact on business, operations, or financial condition as replacement guarantees are finalized.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260727-12256647), on July 26, 2026, and is solely responsible for the information contained therein.